Romain Boidot

27PUBLICATIONS
160CO-AUTHORS
Predictive and prognostic markersMolecular targetsMolecular evolutionHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Jan 13, 2026
Circulating Transcriptome Analysis Finds Gene Signatures and Immune Cell Activation and Abundance Predict Response to Immunotherapy in Bladder Cancer.

Sandy Chevrier, Corentin Richard, Olivier Adotévi

|Jan 31, 2025
PPARα-mediated lipid metabolism reprogramming supports anti-EGFR therapy resistance in head and neck squamous cell carcinoma.

Valentin Van den Bossche, Julie Vignau, Engy Vigneron

|Jan 09, 2025
Nanopore adaptive sampling accurately detects nucleotide variants and improves the characterization of large-scale rearrangement for the diagnosis of cancer predisposition.

Sandy Chevrier, Corentin Richard, Marie Mille

|Nov 14, 2024
CD40 Agonist on Patient-Derived Xenograft Mice for the Treatment of B-Cell Acute Lymphoblastic Leukemia.

Pierre-Simon Bellaye, Aleksandra Georgievski, Paola Ballerini

|Sep 15, 2024
The DAV132 colon-targeted adsorbent does not interfere with plasma concentrations of antibiotics but prevents antibiotic-related dysbiosis: a randomized phase I trial in healthy volunteers.

Meriem Messaoudene, Stéphanie Ferreira, Nathalie Saint-Lu

|May 31, 2024
Impact of scFv on Functionality and Safety of Third-Generation CD123 CAR T Cells.

Maxime Fredon, Margaux Poussard, Sabeha Biichlé

Pageof 5

Frequent Collaborators

10 joint publications

François Ghiringhelli

5 joint publications

Corentin Richard

4 joint publications

Caroline Truntzer

3 joint publications

Sandy Chevrier